The Fourth Wave of the Overdose Crisis: The Role of Psychomotor Stimulants (Online Learning)

US overdose deaths associated with stimulants (cocaine and methamphetamine) are now only exceeded by deaths associated with fentanyl. Because most cocaine and methamphetamine now being used in the US now contains fentanyl and because the methamphetamine currently being produced is more lethal than in past years, these drugs are extremely dangerous and damaging to the body and brain. Individuals who use stimulants are challenging to engage and retain in treatment and they present unique clinical issues in treatment. There are no FDA-approved medications for treatment of stimulant use disorder, although several are promising. Behavioral treatment, especially the use of contingency management (and other approaches with supportive evidence), has by far the best evidence of effectiveness. The presentation will review these topic areas of importance to clinicians treating individuals with stimulant use disorder.

Speaker: Richard Rawson, PhD

Learning Objectives include:

1. Participants will learn details of current epidemiology of overdose crisis
2. Participants will learn effects and consequence of stimulant use
3. Participants will learn current treatments and evidence of support

WISAM is offering Enduring CME for this training until September 26, 2027. Register here and you will receive a link to the webinar recording and CME instructions. This online learning session and CME credit is coordinated by WISAM as part of the ORP.

____________________________________________________________________________

Accreditation & Credit Designation Statements
In support of improving patient care, this activity has been planned and implemented by Wisconsin Society of Addiction Medicine and American Society of Addiction Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians
The American Society of Addiction Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

View Full Learner Statement Here